Literature DB >> 24860098

Bacterial RTX toxins allow acute ATP release from human erythrocytes directly through the toxin pore.

Marianne Skals1, Randi G Bjaelde1, Jesper Reinholdt2, Knud Poulsen3, Brian S Vad4, Daniel E Otzen4, Jens Leipziger1, Helle A Praetorius5.   

Abstract

ATP is as an extracellular signaling molecule able to amplify the cell lysis inflicted by certain bacterial toxins including the two RTX toxins α-hemolysin (HlyA) from Escherichia coli and leukotoxin A (LtxA) from Aggregatibacter actinomycetemcomitans. Inhibition of P2X receptors completely blocks the RTX toxin-induced hemolysis over a larger concentration range. It is, however, at present not known how the ATP that provides the amplification is released from the attacked cells. Here we show that both HlyA and LtxA trigger acute release of ATP from human erythrocytes that preceded and were not caused by cell lysis. This early ATP release did not occur via previously described ATP-release pathways in the erythrocyte. Both HlyA and LtxA were capable of triggering ATP release in the presence of the pannexin 1 blockers carbenoxolone and probenecid, and the HlyA-induced ATP release was found to be similar in erythrocytes from pannexin 1 wild type and knock-out mice. Moreover, the voltage-dependent anion channel antagonist TRO19622 had no effect on ATP release by either of the toxins. Finally, we showed that both HlyA and LtxA were able to release ATP from ATP-loaded lipid (1-palmitoyl-2-oleoyl-phosphatidylcholine) vesicles devoid of any erythrocyte channels or transporters. Again we were able to show that this happened in a non-lytic fashion, using calcein-containing vesicles as controls. These data show that both toxins incorporate into lipid vesicles and allow ATP to be released. We suggest that both toxins cause acute ATP release by letting ATP pass the toxin pores in both human erythrocytes and artificial membranes.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  ATP Release; Bacterial Toxin; Erythrocyte; Escherichia coli (E. coli); Hemolysin; Hemolysis; Leukotoxin; P2-receptors; Pannexin; Phospholipid Vesicle

Mesh:

Substances:

Year:  2014        PMID: 24860098      PMCID: PMC4081947          DOI: 10.1074/jbc.M114.571414

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

1.  Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin.

Authors:  M Iwase; E T Lally; P Berthold; H M Korchak; N S Taichman
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

2.  Escherichia coli haemolysin forms voltage-dependent ion channels in lipid membranes.

Authors:  G Menestrina; N Mackman; I B Holland; S Bhakdi
Journal:  Biochim Biophys Acta       Date:  1987-11-27

3.  Quantitative study of the binding and hemolytic efficiency of Escherichia coli hemolysin.

Authors:  B Eberspächer; F Hugo; S Bhakdi
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

Review 4.  The hemolysin of Escherichia coli.

Authors:  S Bhakdi; N Mackman; G Menestrina; L Gray; F Hugo; W Seeger; I B Holland
Journal:  Eur J Epidemiol       Date:  1988-06       Impact factor: 8.082

5.  Integrin-associated protein: a 50-kD plasma membrane antigen physically and functionally associated with integrins.

Authors:  E Brown; L Hooper; T Ho; H Gresham
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

6.  Effect of Escherichia coli alpha-hemolysin on human peripheral leukocyte viability in vitro.

Authors:  S J Cavalieri; I S Snyder
Journal:  Infect Immun       Date:  1982-05       Impact factor: 3.441

7.  Escherichia coli hemolysin may damage target cell membranes by generating transmembrane pores.

Authors:  S Bhakdi; N Mackman; J M Nicaud; I B Holland
Journal:  Infect Immun       Date:  1986-04       Impact factor: 3.441

8.  Biochemical and morphological characterization of the killing of human monocytes by a leukotoxin derived from Actinobacillus actinomycetemcomitans.

Authors:  N S Taichman; R T Dean; C J Sanderson
Journal:  Infect Immun       Date:  1980-04       Impact factor: 3.441

9.  Effects of a single hit from the alpha hemolysin produced by Escherichia coli on the morphology of sheep erythrocytes.

Authors:  S E Jorgensen; R F Hammer; G K Wu
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

10.  Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells.

Authors:  Seiko F Okada; Wanda K O'Neal; Pingbo Huang; Robert A Nicholas; Lawrence E Ostrowski; William J Craigen; Eduardo R Lazarowski; Richard C Boucher
Journal:  J Gen Physiol       Date:  2004-10-11       Impact factor: 4.086

View more
  25 in total

1.  Liberation of ATP secondary to hemolysis is not mutually exclusive of regulated export.

Authors:  Brett S Kirby; Pablo J Schwarzbaum; Eduardo R Lazarowski; Frank A Dinenno; Tim J McMahon
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

2.  Response: Hemolysis is a primary and physiologically relevant ATP release mechanism in human erythrocytes.

Authors:  Jacek Sikora; Sergei N Orlov; Kishio Furuya; Ryszard Grygorczyk
Journal:  Blood       Date:  2015-03-12       Impact factor: 22.113

3.  Purinergic control of lysenin's transport and voltage-gating properties.

Authors:  Sheenah Bryant; Nisha Shrestha; Paul Carnig; Samuel Kosydar; Philip Belzeski; Charles Hanna; Daniel Fologea
Journal:  Purinergic Signal       Date:  2016-06-18       Impact factor: 3.765

4.  Loop Diuretics Diminish Hemolysis Induced by α-Hemolysin from Escherichia coli.

Authors:  Carl Martin Söderström; Steen K Fagerberg; Mette B Brogaard; Jens Leipziger; Marianne Skals; Helle A Praetorius
Journal:  J Membr Biol       Date:  2017-05-09       Impact factor: 1.843

5.  [Ca2+]i Oscillations and IL-6 Release Induced by α-Hemolysin from Escherichia coli Require P2 Receptor Activation in Renal Epithelia.

Authors:  Mette G Christensen; Steen K Fagerberg; Pauline I de Bruijn; Randi G Bjaelde; Helle Jakobsen; Jens Leipziger; Marianne Skals; Helle A Praetorius
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

Review 6.  Aggregatibacter actinomycetemcomitans leukotoxin: From mechanism to targeted anti-toxin therapeutics.

Authors:  Eric Krueger; Angela C Brown
Journal:  Mol Oral Microbiol       Date:  2020-03-10       Impact factor: 3.563

7.  Inhibition of P2X Receptors Protects Human Monocytes against Damage by Leukotoxin from Aggregatibacter actinomycetemcomitans and α-Hemolysin from Escherichia coli.

Authors:  Steen K Fagerberg; Martin R Jakobsen; Marianne Skals; Helle A Praetorius
Journal:  Infect Immun       Date:  2016-10-17       Impact factor: 3.441

Review 8.  Blood cells: an historical account of the roles of purinergic signalling.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2015-08-11       Impact factor: 3.765

Review 9.  P2RX7 at the Host-Pathogen Interface of Infectious Diseases.

Authors:  Alexandra Y Soare; Tracey L Freeman; Alice K Min; Hagerah S Malik; Elizabeth O Osota; Talia H Swartz
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

Review 10.  Kingella kingae RtxA Cytotoxin in the Context of Other RTX Toxins.

Authors:  Katerina Filipi; Waheed Ur Rahman; Adriana Osickova; Radim Osicka
Journal:  Microorganisms       Date:  2022-02-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.